Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : NASI (North American Scientific, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: richard houchin who wrote (559)	7/8/1998 8:57:00 AM
From: seedy	Read Replies (1) \| Respond to of 658

Hello, I'm a trial member but have been reading this discussion for some time. I'm in the medical field and I am directly involved with the use of these seeds. Here's what I know: 1. Yes, Amersham has increased production, however, their is still at least a 4 week wait for seeds. 2. Amersham does not make Palladium seeds, so NASI has an advantage there. 3. In response to the claim about radical prostatectomy having a better survival rate, this may change in the coming years as there will be a much larger pool of data due to all the new patients who have had implants. Also, patients receiving a prostate implant go home about 4 or 5 hours after the procedure compared to weeks recovery from surgery. 4. One thing no one has mentioned, seeds can be used for other solid tumors, they are not just for prostate cancer. 5. NASI or Mentor is not doing a very good job of marketing their seeds and yet they are selling them all. We tried to order seeds from NASI bacause of the delay with getting them from Amersham. They sent us some paperwork, we submitted it and that was the last we heard from them. Helloooo, you want customers? Here's one. More later. I'm holding.